Will the Newer Oral MS Agents Be Welcomed by Managed Care Organizations?ByRobert J. Lipsy, PharmD, FASHP, BCPSSeptember 21st 2010
Posttest: New and Emerging Therapies for Multiple Sclerosis and the Role of Managed CareBySeptember 21st 2010
The Current Landscape and Unmet Needs in Multiple SclerosisByClyde E. Markowitz, MDSeptember 21st 2010
